Hamlet BioPharma AB (publ)

NGM:HAMLET B Stock Report

Market Cap: SEK 533.5m

Hamlet BioPharma Balance Sheet Health

Financial Health criteria checks 4/6

Hamlet BioPharma has a total shareholder equity of SEK54.2M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK59.3M and SEK5.1M respectively.

Key information

0%

Debt to equity ratio

SEK 0

Debt

Interest coverage ration/a
CashSEK 16.54m
EquitySEK 54.19m
Total liabilitiesSEK 5.12m
Total assetsSEK 59.31m

Recent financial health updates

Recent updates

Is Hamlet Pharma (NGM:HAMLET B) In A Good Position To Invest In Growth?

Jul 04
Is Hamlet Pharma (NGM:HAMLET B) In A Good Position To Invest In Growth?

Here's Why We're Watching Hamlet Pharma's (NGM:HAMLET B) Cash Burn Situation

Mar 04
Here's Why We're Watching Hamlet Pharma's (NGM:HAMLET B) Cash Burn Situation

We Think Hamlet Pharma (NGM:HAMLET B) Can Afford To Drive Business Growth

Nov 10
We Think Hamlet Pharma (NGM:HAMLET B) Can Afford To Drive Business Growth

We Think Hamlet Pharma (NGM:HAMLET B) Can Easily Afford To Drive Business Growth

Jun 17
We Think Hamlet Pharma (NGM:HAMLET B) Can Easily Afford To Drive Business Growth

Companies Like Hamlet Pharma (NGM:HAMLET B) Are In A Position To Invest In Growth

Oct 12
Companies Like Hamlet Pharma (NGM:HAMLET B) Are In A Position To Invest In Growth

Will Hamlet Pharma (NGM:HAMLET B) Spend Its Cash Wisely?

Mar 17
Will Hamlet Pharma (NGM:HAMLET B) Spend Its Cash Wisely?

Financial Position Analysis

Short Term Liabilities: HAMLET B's short term assets (SEK20.7M) exceed its short term liabilities (SEK5.1M).

Long Term Liabilities: HAMLET B has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: HAMLET B is debt free.

Reducing Debt: HAMLET B had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: HAMLET B has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: HAMLET B has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.9% each year


Discover healthy companies